ACRS Competitors & Alternatives
Compare Aclaris Therapeutics Inc with similar stocks in the same industry
Biotechnology
ACRS
Main Stock$5.43
Tradestie Score
63
Market Cap
$202.58M
Revenue Growth
0.4%
Analyst Upside
+84.2%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KOD
Kodiak Sciences Inc Common Stock
|
$43.26
|
$832.47M | - | 67 | Compare |
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$39.19
|
$824.20M | - | 59 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$4.40
|
$821.84M | - | 58 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$56.59
|
$800.41M | - | 52 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$3.93
|
$799.70M | - | 54 | Compare |
|
KURA
Kura Oncology, Inc.
|
$11.24
|
$798.53M | - | 64 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$9.49
|
$791.82M | - | 48 | Compare |
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$11.85
|
$757.72M | - | 61 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$32.54
|
$748.90M | - | 58 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$16.92
|
$726.21M | 7.6 | 52 | Compare |
More ACRS Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry